Titre :
  • Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study
Auteur : Campone, Mario ; Bachelot, Thomas ; Gnant, Michael ; Deleu, Ines I. ; Rugo, Hope ; Pistilli, Barbara B. ; Noguchi, Shinzaburo S. ; Shtivelband, Mikhail M. ; Pritchard, Kathleen ; Provencher, Louise L. ; Burris, Howard H.A. ; Hart, Lowell L.L. ; Melichar, Bohuslav B. ; Hortobagyi, Gabriel N. ; Arena, Francis F.P. ; Baselga, José ; Panneerselvam, Ashok A. ; Héniquez, Aurelia A. ; El-Hashimyt, Mona M. ; Taran, Tetiana T. ; Sahmoud, Tarek ; Piccart-Gebhart, Martine
Informations sur la publication : European journal of cancer, 49, 12, (page 2621-2632)
Statut de publication : Publié, 2013-08
Sujet CREF : Cancérologie
Mots-clés : Advanced breast cancer
Everolimus
Exemestane
Visceral metastases
Mots-clés MeSH : Aged
Androstadienes -- administration & dosage -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism -- pathology
Clinical Trials, Phase III as Topic
Exanthema -- chemically induced
Fatigue -- chemically induced
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Middle Aged
Multicenter Studies as Topic
Neoplasm Metastasis
Placebos
Postmenopause
Prognosis
Randomized Controlled Trials as Topic
Receptor, ErbB-2 -- metabolism
Receptors, Steroid -- metabolism
Sirolimus -- administration & dosage -- adverse effects -- analogs & derivatives
Stomatitis -- chemically induced
Treatment Outcome
Viscera -- pathology
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2013.04.011
info:pii/S0959804913003237
info:pmid/23735704